Codes / ICD10CM / C11.8

C11.8 Malignant neoplasm of overlapping sites of nasopharynx

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of overlapping sites of nasopharynx
  • Nasopharyngeal carcinoma (overlapping sites)

Summary

Malignant neoplasm of overlapping sites of the nasopharynx is a cancer originating in the nasopharynx, the upper part of the throat behind the nose. This condition involves abnormal cell growth in the tissues lining this area, which connects the nasal cavity to the pharynx. It may spread to nearby structures or distant sites if untreated.

Causes

The exact cause is not fully understood, but genetic mutations and environmental factors are believed to contribute. Infection with the Epstein-Barr virus (EBV) is a significant associated factor in many cases. Other potential contributors include dietary habits and exposure to certain substances.

Risk Factors

  • Infection with Epstein-Barr virus (EBV)
  • Family history of nasopharyngeal carcinoma
  • Consumption of preserved or salted foods
  • Exposure to wood dust or formaldehyde
  • Male gender
  • Age, particularly between 30 and 50

Symptoms

  • Nasal congestion or blockage
  • Nosebleeds
  • Hearing loss or ear pain
  • Swelling in the neck (lymph node enlargement)
  • Difficulty breathing or speaking
  • Unexplained weight loss

Diagnosis

Diagnosis begins with a physical examination and medical history review. Nasal endoscopy is typically performed to visualize the nasopharynx. Imaging tests such as MRI or CT scans assess the extent of the tumor. A biopsy of the nasopharyngeal tissue confirms the presence of cancerous cells.

Treatment Options

  • Radiation Therapy: Often first-line treatment, especially effective due to the location's sensitivity.
  • Chemotherapy: Used in conjunction with radiation or for more advanced stages.
  • Surgery: May be considered for localized tumors or to address complications.
  • Targeted Therapy: For cases with specific genetic markers.

Prognosis and Follow-Up

Prognosis depends on the stage at diagnosis, tumor size, and response to treatment. Regular follow-up appointments monitor for recurrence or complications. Imaging and physical exams are typically part of ongoing care.

Complications

  • Spread of cancer to nearby structures (e.g., lymph nodes, skull base)
  • Hearing loss or ear infections
  • Difficulty swallowing or speaking
  • Chronic nasal congestion or blockage
  • Metastasis to distant organs (e.g., lungs, bones)

Lifestyle & Prevention

  • Avoid exposure to known carcinogens like wood dust or formaldehyde.
  • Maintain a balanced diet with limited preserved or salted foods.
  • Practice good hygiene to reduce infection risk.
  • Seek prompt evaluation for persistent symptoms like nasal blockage or neck swelling.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent nasal congestion, unexplained nosebleeds, neck swelling, or other symptoms lasting more than two weeks. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use C11.8 for malignant neoplasms of overlapping sites of the nasopharynx. Document the specific sites involved to support code assignment. Ensure clinical documentation aligns with the overlapping nature of the tumor location.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C11.8 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.